Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by hydrocarbsson Jun 23, 2019 10:06pm

98 Views

Post# 29854537

Exciting presentation at the biennial IPA

Paper 11070-110: A New Platform Technology RuVaCare™, an Extracorporeal Anti-Cancer Vaccine is Efficient in Breaking Immune Barrier to Target Cancer Cells

This paper discusses the successful application of Theralase®’s PDT technology as a cancer vaccine, known as RuVaCare™, and highlights the study’s outcome and the significant increase of survival obtained in the RuVaCareTM vaccinated RG2-GBM model. RuVaCare™ was designed to break the suppressive tumours barriers and to selectively boost the activation of an effective immune response, specifically toward malignant cancer cells.

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property